Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neoplasm Metastasis × Capecitabine × Clear all

Phase

Phase 2 56 Phase 3 20 Phase 1/2 16 Phase 1 14 Phase 2/3 4 Phase 4 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11 Rectal Neoplasms 6 Pancreatic Neoplasms 6 Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Solid Tumors 1 Obesity 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Locally Advanced Rectal Cancer 1 Klatskin Tumor 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Cholangitis, Sclerosing 1 Carcinoma, Hepatocellular 1 Capecitabine 1 Biliary Tract Neoplasms 1 Anus Neoplasms 1 Adenocarcinoma 1

Interventions

Radiosurgery 21 Magnetic Resonance Spectroscopy 11 Cryosurgery 9 Blood Specimen Collection 9 Standard of Care 8 Radiotherapy 7 Surveys and Questionnaires 6 Educational Status 6 Drug Therapy 6 Radiotherapy, Intensity-Modulated 5 Palliative Care 5 Surgical Procedures, Operative 4 Practice Guidelines as Topic 4 Methods 4 Everolimus 4 Radiofrequency Ablation 3 Early Intervention, Educational 3 Cryotherapy 3 Androgen Antagonists 3 Zoledronic Acid 2 Videotape Recording 2 Trastuzumab 2 Radiation 2 Physical Therapy Modalities 2 Manual Lymphatic Drainage 2 Liver Transplantation 2 Liquid Biopsy 2 Letrozole 2 Interviews as Topic 2 Genetic Profile 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03634202 2019-05-15

DESIR

Institut Cancerologie de l'Ouest

Phase NA Terminated

Gastrointestinal

Neoplasm Metastasis, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡